These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 16877972

  • 1. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives.
    Cuspidi C, Meani S, Valerio C, Fusi V, Sala C, Zanchetti A.
    J Hypertens; 2006 Aug; 24(8):1671-7. PubMed ID: 16877972
    [Abstract] [Full Text] [Related]

  • 2. Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives.
    Cuspidi C, Macca G, Sampieri L, Michev I, Fusi V, Salerno M, Severgnini B, Corti C, Magrini F, Zanchetti A.
    J Hum Hypertens; 2001 Sep; 15(9):619-25. PubMed ID: 11550108
    [Abstract] [Full Text] [Related]

  • 3. Change in cardiovascular risk profile by echocardiography in medium-risk elderly hypertensives.
    Cuspidi C, Michev L, Severgnini B, Meani S, Fusi V, Valerio C, Bertazzoli G, Magrini F, Zanchetti A.
    J Hum Hypertens; 2003 Feb; 17(2):101-6. PubMed ID: 12574787
    [Abstract] [Full Text] [Related]

  • 4. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey.
    Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A, APROS Investigators.
    J Hypertens; 2002 Jul; 20(7):1307-14. PubMed ID: 12131527
    [Abstract] [Full Text] [Related]

  • 5. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
    Cuspidi C, Mancia G, Ambrosioni E, Pessina A, Trimarco B, Zanchetti A, APROS Investigators.
    J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
    [Abstract] [Full Text] [Related]

  • 6. Age related prevalence of severe left ventricular hypertrophy in essential hypertension: echocardiographic findings from the ETODH study.
    Cuspidi C, Meani S, Sala C, Valerio C, Negri F, Mancia G.
    Blood Press; 2012 Jun; 21(3):139-45. PubMed ID: 22416806
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice.
    Cuspidi C, Negri F, Muiesan ML, Capra A, Lonati L, Milan A, Sala C, Longo M, Morganti A, Working Group on Heart and Hypertension, Italian Society of Hypertension.
    Blood Press; 2011 Feb; 20(1):3-9. PubMed ID: 20825358
    [Abstract] [Full Text] [Related]

  • 8. Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach.
    Leoncini G, Sacchi G, Viazzi F, Ravera M, Parodi D, Ratto E, Vettoretti S, Tomolillo C, Deferrari G, Pontremoli R.
    J Hypertens; 2002 Jul; 20(7):1315-21. PubMed ID: 12131528
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification.
    Martinez MA, Sancho T, Armada E, Rubio JM, Antón JL, Torre A, Palau J, Seguido P, Gallo J, Saenz I, Polo E, Torres R, Oliver J, Puig JG, Vascular Risk Working Group Grupo Monitorizacíon Ambulatoria de la Presión Arterial (MAPA)-Madrid.
    Am J Hypertens; 2003 Jul; 16(7):556-63. PubMed ID: 12850389
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular risk stratification in hypertensive patients: impact of echocardiography and carotid ultrasonography.
    Cuspidi C, Lonati L, Macca G, Sampieri L, Fusi V, Severgnini B, Salerno M, Michev I, Rocanova JI, Leonetti G, Zanchetti A.
    J Hypertens; 2001 Mar; 19(3):375-80. PubMed ID: 11288806
    [Abstract] [Full Text] [Related]

  • 11. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network).
    Gerdts E, Izzo R, Mancusi C, Losi MA, Manzi MV, Canciello G, De Luca N, Trimarco B, de Simone G.
    Int J Cardiol; 2018 May 01; 258():257-261. PubMed ID: 29544940
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination?
    Cuspidi C, Macca G, Salerno M, Michev L, Fusi V, Severgnini B, Corti C, Meani S, Magrini F, Zanchetti A.
    Ital Heart J; 2001 Sep 01; 2(9):702-6. PubMed ID: 11666100
    [Abstract] [Full Text] [Related]

  • 13. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Oct 01; 25(148):309-14. PubMed ID: 19145927
    [Abstract] [Full Text] [Related]

  • 14. Should we perform an echocardiogram in hypertensive patients classified as having low and medium risk?
    Suárez C, Villar J, Martel N, Extremera BG, Suliman N, Campo C, Castellanos V, Liébana A, Rodilla E, Nieto J, Velasco O, Ruilope LM, GESTHA Study Group.
    Int J Cardiol; 2006 Jan 04; 106(1):41-6. PubMed ID: 16321664
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
    Wang SX, Xue H, Zou YB, Sun K, Fu CY, Wang H, Hui RT.
    Chin Med J (Engl); 2012 Jan 04; 125(1):21-6. PubMed ID: 22340460
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study.
    Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Sala C, Sampieri L, Magrini F, Zanchetti A.
    J Hypertens; 2005 Apr 04; 23(4):875-82. PubMed ID: 15775794
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E, Palermo A, Mulè G, Cusimano P, Cerasola G, Rini GB.
    Eur J Prev Cardiol; 2013 Oct 04; 20(5):854-61. PubMed ID: 22556375
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of left ventricular hypertrophy and carotid thickening in a large selected hypertensive population: impact of different echocardiographic and ultrasonographic diagnostic criteria.
    Cuspidi C, Lonati L, Macca G, Sampieri L, Fusi V, Michev I, Severgnini B, Salerno M, Magrini F, Zanchetti A.
    Blood Press; 2001 Oct 04; 10(3):142-9. PubMed ID: 11688761
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
    Cuspidi C, Meani S, Salerno M, Severgnini B, Fusi V, Valerio C, Catini E, Magrini F, Zanchetti A.
    Blood Press; 2004 Oct 04; 13(3):144-51. PubMed ID: 15223722
    [Abstract] [Full Text] [Related]

  • 20. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M, Cicala S, De Simone L, Caso P, Petrocelli A, Pietropaolo L, Celentano A, Mininni N, de Divitiis O.
    Ital Heart J; 2001 Sep 04; 2(9):677-84. PubMed ID: 11666096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.